Kawate N, Menon K M
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor 48109.
J Biol Chem. 1994 Dec 2;269(48):30651-8.
We have examined whether the two cysteine residues (621 and 622) of the carboxyl-terminal cytoplasmic domain of the rat luteinizing hormone (LH/hCG) receptor are potential sites for palmitoylation. The full-length LH/hCG receptor cDNA was cloned into an expression vector (hCGR-pCMV4). A human embryonic kidney cell line expressing large T antigen (293T cells) was transiently transfected with hCGR-pCMV4 by the calcium phosphate precipitation technique. The functional expression of the receptor was confirmed by 35S-labeled cysteine incorporation into the receptor as well as by 125I-human chorionic gonadotropin (hCG) binding. The transfected cells were then labeled with [3H]palmitic acid, and the labeled receptors purified on hCG-Affi-Gel matrix and subjected to SDS-polyacrylamide gel electrophoresis and autoradiography. The hCGR-pCMV4-transfected cells incorporated [3H]palmitic acid into a 92-kDa band corresponding to the mature form of the LH/hCG receptor; this band was absent in cells transfected with vector alone. Site-directed mutagenesis of either cysteine 621 or 622 to serine residue was partially inhibitory, whereas mutation of both cysteine residues (621 and 622) completely abolished palmitoylation. Scatchard analyses revealed that the mutant and wild type receptors have similar affinities for 125I-hCG. The biological function of palmitoylation was then examined in the transfected cells. The results showed that although the intracellular trafficking of the receptor and the ability to stimulate cyclic AMP production were unaffected, the rate of ligand-induced internalization of the receptor was higher in palmitoylation-deficient mutants compared to the wild type receptors. The first order rate constants of internalization of the mutant receptors were over 2-fold higher than the wild type. Intracellular degradation of the receptor-bound ligand was also higher in the mutants. These studies suggest that the native LH/hCG receptor is palmitoylated at cysteine residues 621 and 622, creating a membrane-anchoring site at the putative cytoplasmic domain. This palmitic acid-mediated anchoring decreases the ligand-induced receptor internalization thereby prolonging the retention of the ligand-bound receptor on the cell surface.
我们研究了大鼠促黄体生成素(LH/hCG)受体羧基末端胞质结构域的两个半胱氨酸残基(621和622)是否为棕榈酰化的潜在位点。将全长LH/hCG受体cDNA克隆到表达载体(hCGR-pCMV4)中。采用磷酸钙沉淀技术将表达大T抗原的人胚肾细胞系(293T细胞)用hCGR-pCMV4进行瞬时转染。通过将35S标记的半胱氨酸掺入受体以及通过125I-人绒毛膜促性腺激素(hCG)结合来确认受体的功能表达。然后用[3H]棕榈酸标记转染的细胞,在hCG-Affi-Gel基质上纯化标记的受体,并进行SDS-聚丙烯酰胺凝胶电泳和放射自显影。用hCGR-pCMV4转染的细胞将[3H]棕榈酸掺入到一条92 kDa的条带中,该条带对应于LH/hCG受体的成熟形式;单独用载体转染的细胞中不存在这条带。将半胱氨酸621或622定点突变为丝氨酸残基具有部分抑制作用,而两个半胱氨酸残基(621和622)都突变则完全消除了棕榈酰化。Scatchard分析表明,突变型和野生型受体对125I-hCG具有相似的亲和力。然后在转染的细胞中研究了棕榈酰化的生物学功能。结果表明,尽管受体的细胞内运输和刺激环磷酸腺苷产生的能力未受影响,但与野生型受体相比,棕榈酰化缺陷型突变体中受体的配体诱导内化速率更高。突变型受体的一级内化速率常数比野生型高2倍以上。突变体中受体结合配体的细胞内降解也更高。这些研究表明,天然LH/hCG受体在半胱氨酸残基621和622处被棕榈酰化,在假定的胞质结构域形成一个膜锚定位点。这种棕榈酸介导的锚定作用降低了配体诱导的受体内化,从而延长了配体结合受体在细胞表面的保留时间。